1Mai KT, Istalo PA, Green J, et al. Incidental prostatic adenocarcino- mas and putative premalignant lesions in TURP specimens collected 14 before and after the introduction of prostrate-specific antigen screening [ J ]. Arch Pathol Lab Med,2000,124 (10) : 1454 - 1456.
2Aytac B, Vuruskan H. Clinicopathologic features of incidental prostat- ic adenocarcinoma in radical cystoprostatectomy specimens[J]. World J Surg Oncol, 2011, 9:81.
3Ruffion A, Mane1 A, Massoud W. Preservation of" prostate during rad- ical cystectomy : evaluation of prevalence of prostate cancer associated with bladder cancer [ J ]. Urology, 2005, 65 (4) :703 - 707.
4Amara N, Palapattu GS, Schrage M. Prostate stem cell antigen is overexpressed on human transitional cell carcinoma [ J ]. Cancer Res, 2001, 61 (12) :4660 -4665.
5Delongchamps NB, Mao K, Theng H. Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for blad- der cancer[ J]. Eur Urol, 2005, 48(6) :946 -950.
3Mai KT, Isotalo PA, Green J, et al. Incidental prostatic adenocarcinomas and putative premalignant lesions in TURP specimens collected be- fore and after the introduction of prostrate - specific antigen screening [ J]. Arch Pathol lab Med, 2000,124 (I0) :1454 -1456.
4Selli C, Montironi R, Bono A, et al. Effects of complete androgen blockade for 12 and 24 weeks on the pathological stage and resection margin status of prostate cancer[J]. J Clin Pathol, 2002,55 (7) :508 - 513.
